Monsanto adds another CRISPR platform to genetic toolbox – Farm and Dairy
|
Monsanto adds another CRISPR platform to genetic toolbox
Farm and Dairy ST. LOUIS — Monsanto Company has forged an agreement with ToolGen, Inc., a biotechnology company specializing in genome editing, to use ToolGen’s CRISPR technology platform to develop agricultural products. The companies announced Aug. 16 that … |
NBC 5 Dallas-Fort Worth |
Achromatopsia: Gene Therapy Cures Eye Disease?
NBC 5 Dallas-Fort Worth Cataldo explained. “There are currently no approved and no effective treatments for achromatopsia,” said University of Florida surgical ophthalmologist Christine Kay. Kay is working to change that. She is one of a handful of experts testing a gene therapy. |
Equities.com |
uniQure (QURE): Gene Therapy Progress in Hemophilia B
Equities.com uniQure (Nasdaq: QURE) is developing gene therapy treatments for hemophilia B (whose patients are deficient in, or have defective, clotting factor IX), Huntington’s disease and cardiovascular disease. Its platform uses adeno-associated virus (AAV … |
ScienceBlogs (blog) |
How Big is Biotech?
ScienceBlogs (blog) Therapeutics, synthetic biology, and other areas considered biotechnology follow similar patterns. In all, the addressable markets for companies in these areas can be between $10’s of millions to $10’s of billions. A harder problem is defining the … |